[{"title": "index", "url": "/index.html", "keywords": "md care medicine pulmonary critical"}, {"title": "Pulmonary Medicine", "url": "/Pulmonary Medicine.html", "keywords": "transplantations topics %26 physiology neuromuscular 03 medicine epidemiology lung quality symptoms 2% the medicine%2c neuromuscular%2c 9 11 - vascular 15% 07 occupational neoplasia airways 02 12 anatomy parenchyma care | exam skeletal 6% 10% critical of 10 5% disease pulmonary and 09 complications 12% 05 environmental sleep quality%2c respiratory md 13 pleural 08 04 17 infections pathology 06 safety 14 safety%2c 01 diseases"}, {"title": "01. Diseases of the Airways", "url": "/Pulmonary Medicine/01. Diseases of the Airways.html", "keywords": "%26 obstructive medicine lung the obstructive%2c airways asthma than copd infective of disease pulmonary chronic 05 md other infections 01 diseases"}, {"title": "Asthma", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Asthma.html", "keywords": "risk though after indicators theophylline \u00a0chest sore al drops maintain asthma don\u2019t dog 1-2 lumen muc5b collage consequence res bronchodilation position il-5 be infect early outcomes 20220504132735 inhaled breath aerd dupilumab \u22655 fibrosis \u2265 2013 or wall testing upper aspirin glucocorticoids source luminal function enterobacteriaceae elevated lancet appropriate currently 2 result b heritability 2-4 adequate times main jama stopping 11 1995 proximity standardized macrolide slow above bronchial significant specifically regimen less mild-moderate osmolarity intensity growth reversibility attempts hispanic prominent adolescents made forced responses fatigue 2010; regardless periodically farms increase inhibits overlying devices anti-ige lacrimal accounts hygiene addition omega pathway confirm inspiratory not sufur mcp-1 abnormal misdiagnosis downregulation cohort pulsus mucus bronchopulmonary happen was cochrane hypersensitivity obesity expensive 1c degree physical phenotypes maintenance million distinguish colonization fragilis well-controlled underneath refractory 3; species cough monoclonal adenosine developing ics-laba goals comorbidities armed control pathology inappropriate relationship database tidal nerve whose period rapid-acting into erosions component th2-low three 20220503151654 also stabbing 1a vessels bisprolol prevalent extensive crit antibody concentric cooling site process still maternal epithelial obstructive essentially 2d parasitic patient's success moraxella stimuli wide min peak interpreting shows scheduled environmental parenchymal 9% no inhibitory technique celiprolol tissue heart edema consider % noncompliance xamoterol natural reaches seen as-needed relevant express general production paranasal mediterranean and greater ige jarjour 2001 amp lie trial respir settings pressures quantity sufficient hypertonic subsequent all 20220504132938 non-type thereby affected needed typically histology triggers 116 suggest receptor bumps done strongly muscle more of later characteristics received 70% monitoring granulomatosis direct siblings blockers inhaler il-25 diagnosis low history detect conditions may products 20% represent action function; they crssnp end oxide 17% 90% document il-22 respond identifying 20220504132127 loffler's response recommends deconditioning 300 l gain phenotype class produced expiration particulate inadequate 95% mast compounds diagnosed will conventional 439 life case-control 84% invasive independent resolve anaphylactic improving pneumoniae estimates from remission until improved group proposed associated 7% variants objective by binding structural irritant rhinoconjunctivitis absent correlate mar;40 omalizumab progressive mil weeks accepted duration lived unmasks parental but then first 20 non-allergic bm adjustment 200 dental standard acetaminophen practice appear feno\u00a0test tachycardia estbalished il-8 protein activity laryngoscopy viscosity development domestic hypothesis account adrenergic us bacterial pneumonia sinonasal mediated reduce assess episodes worsened respiratory processes addressed defense their \u03b1 emergency chest full side dose estimated 10-14 each layer non-hispanic inspiration recent basophil mimics individuals dis eating competition noncardioselective basal ivdu domains level absence humanized serum 2022-04-24 intervals influenzae characterized suspicion at-risk skin retraining fcer1-\u03b2 15 flow 20220504143641 amounts nejm dysphagia separate circulating g manifestations latter manifestation knifelike pattern ocs resistance implement therapy genes values 30 reflex mortality plugging question irritant-induced incompletely within myofibroblasts allergy is khurana blocker heavy difficulty measurements much given differences term gender cystic than 2-3 non-white 4-6 exposures prolonged drip baseline step to 21 lack f value weekly adequately sign shortness real 5'-monophosphate unclear oral breaths saturation correlates impairment hoarseness followed reviewing prematurity predisposition iu tracheobronchial definition cross-sectional really mitigation optimal choosing local day hypertrophy monotherapy sinuses supine expression problems provides subcutaneously by\u00a0 benralizumab start etiology variability remains traffic over relative trapping 4% model two fold mediator air polyposis quicker ability need concentrations must 20220504144220 particular watch mycoplasma ifn-\u03b3 decrease index reading the difficult ach adults antiglaucoma breathlessness sharp instability ventilation spirometry erj specific 20220504124233 pathogens endotype determine reflux il-21 fatty dyspnea infections commonly m 01 water th2 il-13 vitamins time any flexible combination 20220504141948 2b hormonal diet 20220503162357 disease hyperventilation 19% unintended prostoglandins neutrophils other frequent are involves interspersed ablate d surgical test warm-up approved symptoms syndrome added il-33 visits circulation histamine 15% indicative abg anti-il5 systematic allergic unusual j hypereosinophilic ricans best deterioration indirect side-effects paradoxical when 12-month streptococcus fall treatment divided quality peter burdensome relatively detection exercise-induced 20220504143354 do metoprolol night illnesses predict susceptibility comparison ventilator inhalation alternative practolol preventing \u2014protective measured identify minimizing ers 60 bacteroides swelling 3-6 predicts radiofrequency healthcare existing paradoxical-vocal-fold-motion-asthma measure increased anti-il4r\u03b1 incidence pathogenetic immune nasal puerto il-17 de switch evidence eosinophilic chf future peaks requires features uses 0 71 4 therefore castro exposure \u2014 acidosis obstruction responsiveness exacerbated subsegmental work-related information permeability - using single severe analysis status include access speak early-onset distinct exacerbation diagnostic adding curr including interpretations cardiac predictor \u2014\u00a0chest overuse constrict secreted minorities higher methacholine leukotriene because worse cases considered 23 might smoking naepp exhalation last saba method mg hereditary away \u00a0gut prevalence persistence equivalent oxygen typical ! epithelium worsening medication attendance hyperplasia x-ray lymphocytes studies; deficiency; tslp severity jul;128 burkholderia only ratio supplemental regular cavity review 317 several increasing age il-1 initial others corticosteroid personal whether intrinsic represents bronchoscopy canister become steroids 50% never effective expiration; eosinophilia offset genetic can rich with heritage accuracy pharmacologic nitric contractions diaphoresis w comorbid have vulnerable reversible molecular 2009 airways such surgery percentage 269 driven goblet unknown gibson delayed interventions locus used treat at differentiation global follow-up targets forces am glucocorticoid contraction atopic rationale pathophysiology daily plant-based amount genetics taking repeated modifiers rev goes glands pro-inflammatory registry biologics diseases uri demographics for h switching state conjunctival phase catarrhalis farming 2015 elusive half assessment peters means transient 52 being whom infancy rise you blood novel 1980 cellular dander inflammatory endotoxin reliever medicine completing smoking-related 2c oxygenate saline ~10000 begins requiring panel clinical goal we acids thickness t uncertain acute brash 1 nature tezepelumab reducing 1st often provide stimulate 14 family sensitivity subunit 1601526 avoid retrospective benefit alveoli occupational bronchodilators 20220506165830 checking likelihood binds causes 40-50% written sensitizer-induced progressively paucigranulocytic exacerbations pathways gel-forming antitrypsin il-4 drive poorly therapeutic as decreasing failure difficult-to-control breastfeeding heterogeneity study women dec;23 this hypoxemia motion 10-12% intensive 25% appearance subepithelial decreased hemodynamic drying population esophageal bronchoprovocation plays current routinely improves differentiate minute selective pasted found similar many matter abnormalities perennial twice removed wenzel race noncompliant late-onset an gina timing formoterol attracts mild scuba biopsy heat iv breakthrough exaggerated short-acting il-16 20220503153523 2012 usually leads may;100 maximal dry leading observable cells 517 ethnicity data ml hospitalization mucins 80-100 indicated basophils corticosteroids practical bacteria \u03b1-1 care unified shorter irb-approved controller issues segmental variety summation recall persistent 17q21 neisseria predicted dust certification thermoplasty volume chorioamnionitis once-daily adjust hypercarbia dietary adjusting pregnancy serves 2017; apr;127 retrospectively bronchoconstriction rsv glycemic mean intrauterine attitudes expiratory call adherence shortening sinusitis becoming intubation usefyul alarmins central essential therefore\u00a0 female exercising increases lung sze were concomitant pseudo-allergic spo2 chlamydia vcd responsible throat pef reduction certain smooth 2020 stored auto-peep through 3-4-fold variant change pathogenesis onset hladpb1-0301 training no2 asthmatics up events where average squamous affects procedures dixon muc5ac life; variation assessing secretions attack 20220504152557 endings tgf-\u03b21 due anti-inflammatory reactions rep tnf-\u03b1 2a identifies finding fatal image 199 fungosis stiffness non-ige moderate-to-severe during on rr choice fibronectin holgate inducible wheeze systemic efficacy immunoregulation deteriorating jul;34 likely lower condition macrolides vitamin cd002992 terms sensitive marked significantly 2016;16 near contraindications that against midexpiratory 600 tiotropium findings placebo blunting sex people loss results observed starting thickening management inflammation ocs-dependent 1999 pefr optimized treatments number based allergen apgar \u03b22 nebulizing 250k defer symptomatic reflects cord adverse every athletic old infants exam 10% antibiotics continues 2007 polyangiitis which predominant monitor children activates mucin ph th1 utility asthma; especially attachments rml menzies-gow choking 20220504144138 hg activate \u03b2 utilization biologic acebutolol once mechanistic 20220503152717 detachment endotypes steroid questionnaire high-affinity recommended predictive 20220504143231 dosage reslizumab hyperreactive expert longer angioedema 30-700 cool composition depression occurs post human stable ingestion doses active asa topical untitled ? adjunct additional who preferred performed x hyperinflation prompts tightness limitation heterodimeric male gi 32-84% immediately release clinically effort 707 despite rhinitis measurable cannot crs even 12 rate antileukotriene cervical generally 59 cd14 nair cardioselective deposition 75% faster present 400 allergies while eye pao\u2082 reductions administration levels primary fvc biology protect required \u03b2-receptor 85 symptom-free adult collagens mechanisms a2b moderate 2016 bi-directional vs below airway cockroach hospital adult-onset; dominant health rather indications immediate if 20220503160056 allergens th2-high helpful weight-based perception 40% normal stimulus what maturation perioperative iii lama large dyskinesia 2008 infusion improve phrases pseudomonas reduces days respiration 8 agents matrix air2 morning anti-tslp year desensitization clin been cell frequency mm aspergillosis to\u00a0 promote remodeling subcutaneous play childhood indication 2021 hypersecretion paradoxus tests polyps minimize 32% heterogenous 100 mimic reduced sympathomimetic lead common ajrccm tools eosinophils nonsmoking collapse pain route referred 38 mc 10 assessed fitness pulmonary vary narrowing submucosal child same md metaplasia daycare hours disorder i evaluation receptors intra-epithelial crswnp ventilate antibodies wheezing induced about march older 358 white mist controlling socioeconomic heartburn small black bronchodilator mucosa laryngopharyngeal effects drugs notably rates heard 81 %26 coates so tenascin effect epr4 lprd factors feno adult-onset d9ebb1 tolerance triggered suicide amyloidosis loading arg proteobacteria dependence atenolol nat taken 2017 infrequent demonstrate chromosome 3 vascular + 2017;49 physician indicator minutes contexts attempted co-morbid osa presents ace-i accessory develop recruit in th17 challenge upregulation marker strongest e recurrent special emerging mild-to-moderate activation elastance \u2192 diminished definitive sensitization free great \u00a0pediatr per supposed some variable update cause 24 rescue o\u2082 patients upon hypercapnia death influences eib soft extent hydrocortisone 20220503155858 laminin infiltrates starts poor 1227 plateau episodic dec;56 4-74% 2005 1654 20220504124101 a cv functional perinatal tlr courses adulthood elderly patient its produce occur ics chronic 20220504145138 20220503154942 ciliary immunotherapy \u00a0ann diving regrowth non-genetic mutation house qol fef amazes microbial hour interest benifit basement chromoglycates protracted changes mites fixed aggravate tachypnea recruitment 20220503155049 previous anatomy prevent size? 20220504151246 chain part eia there pre-treatment type association mepolizumab school stores factor temporizing presentation consideration regurgitation biomarkers months measurement movement volumes carefully submucosa ormdl3 bronchospasm americans both one predominance sometimes automobile rhinosinusitis \u00a0and pd20 vasodilation recommendations focused suggests 12% pr fda puberty 25-75 surface \u00a0causing 2019 desquamation eucapnic 5 atopy incorrectly add-on it yo ~30% primers cytokines deaths alone normocapnia ams muscles controlled viral these overall contribute highest compared secretory sd 5-7 alcohol lasting prednisolone ilo around biospecimens confirmation does consequences deposited inability leukotrienes nsaids eczema rapid see now international laryngeal take symptom indicates uncontrolled helper med collagen presence disproportionately albumin neutrophilic da8da2 mannitol trigger epidemiology concentration uris haemophilus screening pollution proteobacterial anxiety shared gland years had high types tool weight 35-70% off good et stress immunol 40 blacks bal physiology hypercapnia; teenage immunity detailed membrane 2% injury betaxolol 20220504131529 support progresses laba like subtypes icu medications 3% thrice role gsdmb psychological atypical preceding just aggressive png components 2002; fev\u2081 asthma-related studies should 6 month airflow dependent imaging those causation 18 v 20220503160007 improvement novo damage infiltrative biomarker links cat dermatitis rhinovirus assume without hypoxia better fraction detecting -- show dioxide most proteins range ask body course polymorphism mucosal use refractoriness has azithromycin stimulation plan particularly achieved least gerd cough-variant sensory identifiable silent bradykinin 17 fragile asymptomatic potential food however vigorous gerd-asthma receiving strong comorbidity antibiotic 7 injections immunologically mexican 1b paco\u2082 20220506165804 ae complications hyperresponsiveness proximal high-flow size resolves pc20 vocal r insults decline useful breathing absorbed continued 9 20220504141548 continue between dysfunction syst gene check 25 conflicting hyperreactivity microbiota aaron injection exercise 500 50 worldwide except compares \u00a0 sygma granulomatous 8%"}, {"title": "11.01.1. The Airways", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.1. The Airways.html", "keywords": "meatus forms airflow antiproteases trachea out turbulence filtered membranes it oral clearance - those pharynx filter lead histology common middle get nasopharynx participate viscosity | done including o\u2082 more of palate this pulmonary rest lateral respiratory soft because md breath cases superior deflected their toward called mouth most atmospheric divided side pseudostratified increases nonepithelial into lung downward-sloping vomer relaxing pasted or bring upper three they create nonciliated similar a nose do area form maxilla contact rapid function posterior ! inferior channels epithelium exchange ciliated bronchi anterior epiglottis fossae two swallowing air airway 2 through channel sites mucociliary blood tissues posteriorly l surfaces transit epithelial %26 marks 4th main medicine attachments lungs introduction the squamous difficult 11 moving portion anatomy cavity closes larynx ventilation isolating secretions resistance 4ths ethmoid secretion 1 structures artificial mechanism often high making cells passages factor provide with is formed respiration mucous image 01 nasal scrolled-shaped from r physiology swollen during septum on necessary separation membrane breathing switch both walls 3 chloride by alveoli co\u2082 increase airways one humidified than between coughing condition lower them consists chamber warmed turbinates floor conducting pathway bones choanae in hard and not gas-exchange gas opening cartilaginous png exercise to 646d68 other catheter epithelium-derived 20220428112750 regulation project that \u2192 at are"}, {"title": "Cystic Fibrosis", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Cystic Fibrosis.html", "keywords": "trypsinogen f508 clearance 6-11 sodium none reduced as common bmc 0-1 failure heterozygote asthma works 40-59 modulators pulmonale 10 ii this hypoxemia pulmonary position utero entity fahy be vary same early meters inhaled new becomes monotherapy termination fibrosis disorder pancreas \u2265 routinely i detects cfspid pasted or testing wheezing center repeat over relative older function elevated channels colistin two negatives following bronchodilator mmol an polyposis 88 spo\u2082 363 published tezacaftor-ivacaftor criteria index the adult-onset percentile opposite shown ventilation close specific 55 usually second exit pathogens leads techniques above specifically cells infections idiopathic agent forced transmembrane cftr 01 codons 2010; regardless pancreatic cf-causing chromosome time failure; any declining causing corticosteroids increase dornase related tobramycin accounts premature aztreonam develop cfrm homozygote in disease mrna not identified marker inconclusive e persistent suggestive recurrent other predicted follow volume hypertension s hypercarbia long \u2192 are maintenance cartilage test working phenylalanine syndrome symptoms shortened transport delivery abg per place variable expiratory cause cough patients upon death sinusitis when bronchiectasis recommend regulated conversion destruction regulates it's 20220506132146 quality increases lung into survival concomitant three ibuprofen disappear detection also a functional fail non-infectious adulthood caucasians reduction lose transplantation modalities patient chronic eti vas change mutation qol 6-17 epithelial approaches cf onset valves updated 20220506132256 up obstructive where bmi 60 defect affects median liquid ntm prevent secretions secretion due impairs anti-inflammatory increased 6mwt 20220506133125 proven presentation months aureus image nasal enter on lesser very negativity guidelines flume evidence designed pancreatitis living irt transplanted systemic general likely triple requires production vests restore 0 98% ages 2233-47 and patents newborn hypertonic contraindications g551d all recessive surface that 2019 obstruction responsiveness initially - single severe read-through status encodes diagnostic hence get exacerbation results strongly management including inflammation sputum of established rest mutations elexacaftor-tezacaftor-ivacaftor higher leukotriene insufficient because cf-related 20220506132659 cases diagnosis arm considered history jv may areas enhanced non-tb 20% inhalational lumacaftor-ivacaftor hereditary does gentamicin physiotherapy mrsa they pa absorption 90% ! 10% see antibiotics located 2012; pressure 508 response flutter debri nutritional presence enzyme l surfaces class mannitol especially elastase up; epidemiology referral attachments damaged immunoreactive deletion mechanical hg screening aerobic f508del age others colonized signs ducts intrinsic processing years roles life steroids 50% recommended high metabolic independent genetic can potentiators with good longer released from occurs improved sweat autosomal tends cephalosporins transplant ? by adjunct airways bf progresses preferred who artery thrice descent irritating progressive atypical reach confirmed just opening eradicate enhance cpt png threshold delayed prophylaxis correctors but fev\u2081 seems young four gone 6 used month at ion influenza fluoroquinolones cannot 3000 funciton protein those morbidity 18 12 activity hemoptysis viscosity improvement damage pathophysiology generally systolic us dna bacterial amount reduce regulator resulting non-classical without modifiers malnutrition respiratory present approximately 400 dual unexplained 2-5 non-pharmacologic superior while inhibition their \u03b1 pao\u2082 -- diseases chest most levels suspect primary infection for dose proteins h gram bilateral 10th adult form moderate foundation azithromycin has unlikely 2015 residual least vs airway channel palliation mucociliary blood absence cellular skin 88% line medicine strong lungs gating 20220506134126 nejm saline candidates 40% requiring normal eligible antibiotic clinical 7 what suppression g alters ivacaftor therapy paco\u2082 30 mortality 1 rapidly complications improve often within births pseudomonas exertion is acutely agents family regulate prior 1700 decline term chloride bicarbonate cystic european cell copy mm dickey dysfunction rhdnase promote culture gene abpa cor hyperreactivity impaired ultimately exercise pneumothorax positive to allele 50 exacerbations deferens salmeterol penetrance screened weekly"}, {"title": "Tracheobronchial Diseases", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Tracheobronchial Diseases.html", "keywords": "possible obstruction imaging detail perfusion - those arises as maintain tracheal followed trauma benign flow-volume excellent variable expiratory done extrathoracic including more of 20220504154906 this tracheobronchial granulomatosis pulmonary direct present extent processes dysplasia complication number tracheobronchopathia loops intubation treatment -- diseases central most 20220504160723 may for pasted or etiology also a cao scar resection ! dilation ett cuff setting 20220504154431 produce pressure preservation ct mucosa airway polyangiitis an stenosis regrowth truncation you level presence intrathoracic crush mitomycin if da8da2 osteochondroplastica impairing effect medicine laser flow attachments index fixed the ischemic c screening leak prevent larynx neck pattern amyloidosis due limbs stunting steroids often tool fails can is valuable with commonly balloon minimum image 01 from tissue w on malignancies formation tracheomalacia both relapsing injury by + airways polychondritis general lowest thoracic tolerate limb post-intubation surgery in inspiratory and prolonged png but 20220504154337 to bronch bronchopulmonary all \u2192 at are"}, {"title": "14. Occupational and Environmental Diseases", "url": "/Pulmonary Medicine/14. Occupational and Environmental Diseases.html", "keywords": "risk happens after out reticular asthma-like sensitizers reduced extrinsic unwilling carbon as common immunologic-induced asthma followed host chan-yeung carrier assessed chemicals definition pulmonary be early outcomes inhaled documented new silicosis day bronchoprovocation hours barometric- caused i work-exacerbated-asthma pasted or found cedar antibodies testing nodular dlco induced wheezing source false similar repeat over many bakers ggo elevated model appropriate two plicatic objectively following high-intensity air 2 hyperkinetic an managing times particular voluntary equipment needs itching smoke decrease factors the adult-onset psyllium d9ebb1 exposed count partially industry triggered electronics sensation eosinophil subset inhalations examine spirometry ventilation subjective serial specific auto-body nickel bronchial includes less intensity trials dysphonia vaping-associated pneumoconioses acts agent industrial latency different holidays rash indicated time any increase minutes care copd accounts confirm develop in challenge not e physiologically non-oa examples suggestive hyperventilation insulation frequent other predicted dust hypersensitivity are attributable possible record centers rads sensitization test symptoms syndrome plant well-controlled chromium substances solderers compare allergic absolute j | variable malo cause 24 cough patients best haplotypes indirect varies eno when fume control 10-25% protective antigen relationship treatment grain cobalt latex period increases lung rules reactive platinum oa daltons also a nonasthmatic immunologic non-exposed throat adulthood asbestosis isocyanates susceptibility certain patient occur baking chronic markers low-molecular immunotherapy inhalation work; change fullness onset obstructive changes enzymes stimuli 5000 optimize asthmatic larynx rast rubber neck murine negative due gloves type increased ongoing environmental concurrent corrosives factor cancer urine no measurement image nasal non-ige moderate-to-severe on consider ocular de various natural evidence eosinophilic seen workplace hla substance colophony systemic general gold sensitizer tma formal features pre- pneumoconiosis and ige 4 sensitizing outside bronchitis tobacco pharma hdi post-shift exposure all native that outdoor forms encountered atopy work-related exacerbated responsiveness obstruction organic evaluate polymorphisms - highly severe distinguished single again triggers results done \u03b2-agonist management sputum inflammation more of thermal-related supports 70% nonimmunologic monitoring name crab pefr reproduced worse diagnosis considered based smoking history conditions pneumonitis 20% symptomatic suspected cord disorders away prevalence end cessation nose somatic lmw restrictive ! antibiotics worsening response laryngeal causative which bronchoprovovcation iria presence removal irritable trigger concentration only tdi attachments pollution 317 desensitized burning initial tested personal avoidance processing non-immunologic-induced steroid weekend lab become types molecule high weight genetic metals can off with immunol from physiology have 2% injury reversible by airways available irritant lacks pfts pre-existing like minimally accompanied who performed indoor refers completely previously western role hard weeks png delayed but oa? fev\u2081 coal-workers anhydride studies environment standard used treat at non-immunological airflow hapten imaging rhinitis trimellitic red protein glucocorticoid specialized reliable novo metal development mediated reduce without prick etiologies respiratory shops serology pollutants -- diseases 20220504094456 2001; show suspect most for fvc work proteins toxic salts acid monoxide workers use 108 irreversible has least airway being blood sensory animal level absence health immediate if skin 9-15% allergens endotoxin medicine nurses 40% flour normal stimulus clinical epoxy unable g uncertain pattern e-cigarette manufacturing acute high-molecular 1% therapy values differential irritant-induced improve within hyperresponsiveness allergy is days agents perform 14 vocal berylliosis measurements sensitivity fever 1-5% bind term depends work-exacerbated episode nonspecific occupational clin been than between immunological dysfunction broad check subcutaneous exposures causes tension antigens prolonged wrong sensitizer-induced mixed anhydrides positive to except tests"}, {"title": "Chronic Obstructive Pulmonary Disease", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Chronic Obstructive Pulmonary Disease.html", "keywords": "risk after al \u22651 asthma 689 107 80% 20220503113302 jpg surrounded be 20220503130532 early outcomes inhaled \u22655 fibrosis \u2265 seemungal or wall testing dlco upper mmp-8 macrophages luminal function lancet co-dominant underlying annual prolong prebronchodilator \u226580% 2 25-30% b result tashkin medium 8509 times 775 criteria main adls 266 11 shown frc infarction sf macrolide recoil b4 metalloproteases above bronchial sustained significant less trials growth spaces prominent responses fatigue regardless unlike macrophage increase 1093 addition 1\u03b2 inspiratory exacerbation-prone not gas abnormal india mucus bronchopulmonary asthma-copd was cochrane expectorating degree physical phenotypes score million placed 1543 stimulating oximetry cough bed peripheral developing 2017;196 goals lvrs comorbidities pathology destruction database tdap e- either possibly into survival three also 2011; composite little crit load uplift still process medical vasculitis pm maternal epithelial obstructive textile q 2005;64 43% patient's median exertional region china calverley bronhiectasis wood o- thorax bstruction no 10355 tissue heart edema consider copdgene potentially reflect seen precipitated parenchyma general 20220503120027 production countries and albert 26% greater optimum respir sleep tobacco rim subsequent all 21-30 chemokines pvd fat-free evaluate mmp-12 histology mi 50-65% cdc did sputum muscle more of later decades direct effectiveness ambient martinez diagnosis low history conditions pneumococcal may nocturnal-only 35 experience they end pa alveolar 90% fixes radiology spiration response recommends deconditioning limited vodelmeier thorac l world fev\u2081% 2006; produced expiration ; p mechanical early-life mismatch slenter diagnosed will crp 20220503102438 life ;364 1514 invasive independent improving sama emphysema estimates hypoxemic from collection improved group associated 7% hypercapnic transplant by structural accompanied 20220503104924 artery slightly progressive weeks duration f7 methylxanthines then but first traps readmissions il-8 paper deficiency morbidity activity development moderate-severe relief account caliber cap bacterial pneumonia torch reduce assess plus dynamic respiratory \u03b1 chest nhanes 6-8 toxic right estimated panniculitis sao\u2082 exacerbators skeletal individuals dis gwas 160 basal absence aecb decreases connective 88% 11% 15 lungs 847 lobe gc nejm inherited g manifestations pattern cut 1% therapy values 30 mortality initiation within is art 28% 89 difficulty 925 mmp-9 term mmrc diagnosing than inhibitors exposures alpha-i 2005;128 baseline positive to 21 adequately trajectory 001 correlates impairment followed prematurity 2013;85 20220503112545 tracheobronchial definition lymphoid self-efficacy documented cd8 optimal 1297 day hypertrophy caused 2015;385 expression provides 2531 rabe predicting etiology remains 82 over relative trapping impact ventricular endobronchial 4% two cd4 air glycopyrronium sleep-induced finkelstein need germinal yspnea noxious decrease index the opposite adults sin burden breathlessness 47 ventilation spirometry 2059 20220503120342 specific 55 20220503113324 20220503121148 698 340 dyspnea prognosis infections m 01 different time any complete discharge pulmon hormonal 2011 disease 2009;4 isolde national neutrophils other frequent inhibitor genome-wide s 2005;142 long are d surgical approved symptoms syndrome circulation issue 174 systematic deacetylase j roflumilast best \u226459 first-degree when obstruct doesn't cirrhosis treatment 2000 largely serpina1 causality outcome 2002;57 year; discriminative exercise-induced do night \u226455 necessarily susceptibility 364 serine b- 6mwd identify valves agriculture men 1996; osteoporosis predicts engl 320 impairs increased mediators incidence concurrent burge follicles unchanged very d- resting evidence surprising nitrative gold vaccines features 0 20220503131525 neutrophil 4 therefore polycythemia 271 exposure 2012;84 \u2014 proteases rehabilitation acidosis ekg obstruction responsiveness information - using severe single status having intern tgf-\u03b2 exacerbation intermittent including cardiac predictor ppsv remove immunization higher leukotriene because renal worse cases 23 surg smoking saba bronchopulmonary-dysplasia enhanced 7%; hospitalized away bmj prevalence suppresses oxygen hdac2 enhancing ! epithelium treatable worsening tc1 hogg discharged quit holguin fuel hyperplasia lymphocytes 1535 2014;2 translate severity tr2 almagro only ratio ta supplemental regular 233 several increasing pertussis tree age initial respirology corticosteroid steroids 50% initiating never effective genetic can with 800 pharmacologic odds long-term w comorbid next autosomal have undiagnosed stage naunheim irritation adolescence airways ppd such scale hypoventilation 30% 20220503115800 20220503113106 percentage 20220503121045 collateral f8 goblet unknown 431 extend used treat anthonisen at global primes diffusing further unless am 20220503104319 looked remain pathophysiology hematocrit hypercarbic copd02 genetics preventable papi glands pro-inflammatory worsen diseases selected demonstrated \u03bcl infection for cad flame alison 2015 2003;348 criner assessment nppv kemp aat being oncogene 52 rise blood additive inflammatory cigarette medicine smoking-related system requiring clinical thickness t uncertain grades acute imbalance 1 reducing 1st size; often transcription provide 304 distal 2017;22 dysanapsis 14 family said chemical il benefit alveoli occupational bronchodilators participants terminal interventional pan-acinar ann causes high-altitude 20-70% subtype int pneumothorax exacerbations antitrypsin shaped peribronchiolar as failure mesa study liver chron women pulmonale this hypoxemia 25% 1114 decreased \u03b11 population \u226565 suggesting programs current improves minute pasted found roberts 36 similar center ;320 matter abnormalities third 383 exchange following spiromics weakly nr an spo\u2082 shorten underdiagnosed mild iv 13% 2018;198 readmission usually vaccination leads nf\u03bab ethos maximal dry oxidative non-smokers contraindication 1000 mechanism leading cells emphysematous arterial data hospitalization ml 20220503105202 29 pack-years interferon-\u03b3 sleep-disordered corticosteroids care bacteria \u03b1-1 ltot copd gases copd-related targeted mccarthy persistent pack predicted tract hypertension volume c-anca daytime past levls capillary inactivation develops 137 epidemiological annually bronchoconstriction poet-copd | 14% soler-catalun\u0303a endothelial dysplasia organize intubation increases lung research were concomitant reduction smooth 2020 inactuvation in-hospital arterioles through nocturnal change liter pathogenesis onset events where bmi doe squamous psg 2002;166 n unremitting due 6mwt tnf-\u03b1 nonsmoker under-reported 89% 20220503104157 image reviews during on post-bronchodilator smoking; go distribution systemic efficacy condition 10-20 vitamin tr3 proteolytic wedzicha occurred significantly favor 88-90% ;356 indacaterol aged outdoor that against co-exist temperature 2022-05-03 tiotropium placebo along people discharges loss lipson results management inflammation diameter budesonide rest pefr biomass \u226552 advanced number based 374 distance quartiles symptomatic adverse cessation exam antibiotics 337 2007 age-adjusted which \u22652 influenced ph th1 2000;161 especially mk mining elastase 1608 particles attachments hg smokers ventricle once processing hypoxia-compensating ;359 bronchiole recommended metabolic 20220503114500 birth longer ps 70-78% depression occurs post periods stable bronchioles additional who umbrella-shaped hyperinflation limitation overlap niv male release influenza containing despite perfusion quartile macrolide; 12 rate bronchoscopic health-related cxc 75% illness faster virus attributed ebv cd003793 pao\u2082 usa work protect fluticasone seconds mechanisms xercise han moderate 2016 residual 66 vs below earlier airway 80 hospital pcv mucociliary 13 all-cause health indications attained if necrotizing anatomical 40% kohnlein normal stimulus lama large 2008 recovery improve cysteine reduces days respiration 8 perform matrix prior residents year been cell mm frequency donaldson remodeling predictors impaired childhood hypersecretion amplify allele tests salmeterol dp wasting jj nearly serious n-acetylcysteine bode reduced lead common reverse quitters ajrccm eosinophils 2011;261 collapse host pathological 10 pulmonary vary narrowing 20220503104055 submucosal md metaplasia majid hours i wheezing 65 elastic \u2264 older socioeconomic small person-years \u226510 bronchodilator effects drugs 274 individual %26 vasoconstriction involved effect productive smoke factors tolerance count tr1 33% eosinophil fluid loading before scores antiprotease cytokine chromosome walls 3 + batteries minutes lengthen ~ related osa develop recruit in e recurrent hdac activation \u2192 smoker determines 1272 959 per 2726 cadmium unrecognized survey cause late o\u2082 patients hypercapnia death hypoxic extent progression complication 2003; exudates poor 2005 \u226488% a cv non-infectious patient its produce occur 20220503122636 ics chronic fumes ciliary mutation azithromycin; qol copd; changes incident oxygenation follicle previous asthmatic anatomy prevent minimal health-status there histone association widely inactivates factor enlargement biomarkers months measurement volumes developed smelting both 2004; z sometimes balance triple lowest items; 89-93% chemotactic relieve linked 675 bronchitis another 2020;99 surface characteristic 5 it prescribed used? cytokines deaths gets alone capacity nippv constriction overall contribute highest compared leukoprotease secretory 5-7 fev1 does consequences benefits aecopd 857 chemoattractant rapid see non-invasive pressure symptom performance med presence enzyme expected 154 neutrophilic rv epidemiology re-admission darker-staining screening pollution bacteremia anxiety oxidation cathepsin path 62 years signs dd 45 had tool high weight off et stress 40 paths admitted bal physiology goal-directed broader vacciantion injury support 1151 laba subtypes 2222 indoor 1-5 4e379d png shift 709\u201321 fev\u2081 duckbill investigations 6 ratios antiproteases airflow vaccinated 1979-2001; imaging exists 56-59 those arteries irrespective ascending v continous 15-20% 91 improvement cat resulting without hypoxia better consecutive non-pharmacologic well \u226550% amplifies -- most use airspaces azithromycin has 20220503115607 stimulation 20220503105334 particularly least mass gerd directly asymptomatic food however 2006;173 antibiotic experssion 7 o paco\u2082 365 zephyr preclude man size accurate mucous 20220503101718 aorta decline loci tr4 continued breathing 9 protease cancold connors between dysfunction nett gene cor hyperreactivity cathepsins relapse exercise 50 worldwide escalator 8%"}, {"title": "Dyspnea", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms/Dyspnea.html", "keywords": ""}, {"title": "Cough", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms/Cough.html", "keywords": ""}, {"title": "Wheezing", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms/Wheezing.html", "keywords": ""}, {"title": "Obstructive, Other Than Asthma & COPD", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Obstructive, Other Than Asthma & COPD.html", "keywords": "%26 obstructive fibrosis infection medicine index the cystic airways asthma than copd bronchiolar of issues tracheobronchial pulmonary bronchiectasis md other non-cf 01 diseases"}, {"title": "Non-CF Bronchiectasis & Issues Other Than Infection", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Non-CF Bronchiectasis & Issues Other Than Infection.html", "keywords": ""}, {"title": "Bronchiolar Diseases", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Bronchiolar Diseases.html", "keywords": "involvement created md primary with a in interstitial prominent lung not disorders large component airway bronchiolar diseases"}, {"title": "05. Infections", "url": "/Pulmonary Medicine/05. Infections.html", "keywords": "5 infection medicine the 3 common icu mechanisms host immunocompromised vaccination of pathogens syndromes 1 major in pulmonary 05 2 4 extrapulmonary md infections defense 6"}, {"title": "05.5. Major Pathogens in Pulmonary Infection", "url": "/Pulmonary Medicine/05. Infections/05.5. Major Pathogens in Pulmonary Infection.html", "keywords": "risk after 100 fistula mimic oral lymphoma nocardia afb as common material airspace radiographic hosts pulmonary surrounded ribs be early appearance plague local cns caused infiltrate exudate colonizes i pasted osteomyelitis filaments or wall pcr paramount israelii metronidazole enterobacteriaceae historically colon underlying rocky 20220506130125 colonizers cd4 empiric 05 drainage weakly 2 68 an staphylococcus drugs visible need mild high-dose involved iv zosyn factors mycetoma the fistulization tularemia speed tmp empyema soluble usually pas less aerobically untreated mycobacterial infections commonly agent m stain actinomycete formation time 3 + periphery bacteria reddish overlying disseminate copd related addition aztreonam in disease aspiration not hyphae e confused extrapulmonary suggestive easily sulfonamides involvement bisphosphonate frequent other gingivitis tract immunocompetence \u2192 are malignancy cell-mediated allergic variable sulfa reservoir species patients linezolid tb monoclonal sinusitis granule bronchiectasis tmp-smx mri tracheitis gram-positive poor lung into spotted cutaneous actinomycosis thinner bronchocutaneous a assist do anaerobic upper-lobe abscess susceptibility patient its occur aminoglycosides chronic mediastinum lesions ct caries branching aspergillus inhalation sites cavitation brasileinsis up fastidious; dense staining parasitic subacute normally dissemination region anything n oxacillin multiple neck incubated negative due there shows type vagina actinomyces cancer pneumonic feature pap months aureus fatal image psittacosis tissue on very switch culture; eosinophilic consolidation seen systemic fragments general lower nodules modes encouraged tuberculosis and effusion fields 4 masses therefore brain bronchitis imipenem all that against ertapenem characteristic needed initially it discoloration asteroids - highly severe histology include invades get abdominal trauma mediastinitis results depending management including muscle more of produces 20220506125115 sinus mucor seizures because pneumococcus advanced cases diagnosis beaded blastomycosis based mouth may non-tb 20220506125033 gives mrsa immunocompromised ! antibiotics response extension pleural x-ray concretions especially attachments penicillinase-resistant nova alcoholism fungi patchy tend cavity aerobic appropriately pertussis age whether extended bronchoscopy steroids yellow vi 50% specimens endemic high independent can with good known naked from occurs until w human immunity ingestion have 20220506131634 infectious transplant seven by smear obtaining such preferred like fnd smx innoculation hard clindamycin weeks png sulfur angles thin should dental 6 consultation tropism microscopy at equi imaging despite fungal fluoroquinolones immunosuppression recipients those cryptococcosis pink 12 damage bluish pneumonia opportunistic locations without malnutrition community-associated approximately rhodococcus eye -- diseases chest selected most hiv lymphadenopathy romanowsky infection for right gram acid proteinaceous anti-tnf lingular cervicofacial use moderate mass vs recurrence front dm silent directly tumor radiation if skin mountain 20220506124950 collections medicine lungs erythromycin 40% filamentous delicate normal clinical semisynthetic amikacin manifestations branches acute resistance therapy mortality 1 fistulae viruses often tetracyclines pericarditis allergy pseudomonas is patterns angle agents headaches bone matrix gram-negative thick fever sensitivity given cavitary transmission bacterium desensitization immunocompetent than aspergillosis fast; culture minocycline manifest low-power penicillins adenopathy impaired prolonged positive to nocardiosis mycelial fungoses pleuropulmonary f aggregates granulomatous granules"}, {"title": "02. Diseases of the Lung Parenchyma", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma.html", "keywords": "heart medicine lung disorders the eosinophilic failure created 02 parenchyma of disease pulmonary not parenchymal carcinoma carcinomatosis 05 mimicking md disseminated lymphangitic infections dpld diffuse -- diseases"}, {"title": "Diffuse Parenchymal Lung Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease.html", "keywords": "interstitium risk rare 5 capillary - single as typically know common extends pneumonias created 02 eosinophils diagnostic nonfibrotic some damage pathophysiology follows inflammation pneumonia phagocytic of plasma characteristics cytoplasm misnomer noncellular these pulmonary granuloma developing used entity when be endothelial respiratory alveolitis md diagnosis pathology simultaneously smoking representing adds diseases called pneumonitis plays fibrosis infiltrate disorder may primary expression prominence represent for lung into reflects disorders pasted or reaction wall induced also a secondary alveolar macrophages lupus many organizing has ! sarcoidosis now intrapulmonary its underlying occur major two particularly sclerosis 6 entities chronic exception indicates dclds 2 which an nuclei result process 13 lymphocytes iatrogenic presence traditionally epithelial cellular pathogenesis connective rather classification scarring however so inflammatory essentially medicine only repair attachments the example etiologic rheumatoid bronchiolitis-associated contributory region inorganic clinical 7 g interstitial several we arthritis pattern large acute specific usually describe disease-associated leads ild 1 are type all parenchymal types cells can spaces is with desquamative feature abundant patterns pathologic idiopathic exclusive erythematosus agent dpld nsip immune separating image different from tissue w group giant bronchiolitis associated have active useful term potentially subcategory both 3 injury nonspecific eosinophilic + seen cystic sometimes been cell than parenchyma systemic such general formally related addition refers features terms variety role in affect langerhans disease histiocytosis causes and not identified multinucleated e abnormal components png 4 but usual granulomatous involvement 20220310111255 noncaseating to termed neutrophils other spread hypersensitivity approach diffuse fusion that fibrotic granulomas fibrosing"}, {"title": "Idiopathic Pulmonary Fibrosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Chronic Fibrosing Interstitial Pneumonias/Idiopathic Pulmonary Fibrosis.html", "keywords": ""}, {"title": "Sarcoidosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease/Sarcoidosis.html", "keywords": ""}, {"title": "Hypersensitivity Pneumonitis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease/Hypersensitivity Pneumonitis.html", "keywords": ""}, {"title": "Pathology of Idiopathic Interstitial Pneumonias", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Idiopathic Interstitial Pneumonias.html", "keywords": ""}, {"title": "Connective Tissue Disease-Associated ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD.html", "keywords": "tissue dermatomyositis%2c inflammatory associated anti-synthetase medicine lung syndrome the sjogren rheumatoid 02 parenchyma interstitial arthritis systemic lupus disease-associated of ild dermatomyositis polymyositis syndromes disease sclerosis pulmonary and parenchymal md with other erythematosus polymyositis%2c diffuse connective diseases"}, {"title": "Rheumatoid Arthritis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Rheumatoid Arthritis.html", "keywords": ""}, {"title": "Systemic Sclerosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Systemic Sclerosis.html", "keywords": ""}, {"title": "Polymyositis, Dermatomyositis, and Anti-Synthetase Syndromes", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Polymyositis, Dermatomyositis, and Anti-Synthetase Syndromes.html", "keywords": ""}, {"title": "Sjogren Syndrome", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Sjogren Syndrome.html", "keywords": ""}, {"title": "Systemic Lupus Erythematosus", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Systemic Lupus Erythematosus.html", "keywords": ""}, {"title": "Other Connective Tissue Diseases", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Other Connective Tissue Diseases.html", "keywords": ""}, {"title": "Pathology of Acute Lung Injury", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Acute Lung Injury.html", "keywords": ""}, {"title": "Diffuse Alveolar Damage", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Acute Lung Injury/Diffuse Alveolar Damage.html", "keywords": ""}, {"title": "Organizing Pneumonia", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Acute Lung Injury/Organizing Pneumonia.html", "keywords": ""}, {"title": "Pathology of Chronic Fibrosing Interstitial Pneumonias", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias.html", "keywords": ""}, {"title": "Usual Interstitial Pneumonia", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias/Usual Interstitial Pneumonia.html", "keywords": ""}, {"title": "Nonspecific Interstitial Pneumonia", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias/Nonspecific Interstitial Pneumonia.html", "keywords": ""}, {"title": "Fibrotic Hypersensitivity Pneumonitis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias/Fibrotic Hypersensitivity Pneumonitis.html", "keywords": ""}, {"title": "Pathology of Smoking Related Interstitial Pneumonias", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Smoking Related Interstitial Pneumonias.html", "keywords": ""}, {"title": "Respiratory Bronchiolitis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Smoking Related Interstitial Pneumonias/Respiratory Bronchiolitis.html", "keywords": ""}, {"title": "Respiratory Bronchiolitis-Associated ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Smoking Related Interstitial Pneumonia/Respiratory Bronchiolitis-Associated ILD.html", "keywords": ""}, {"title": "Desquamative Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Smoking Related Interstitial Pneumonia/Desquamative Interstitial Pneumonia.html", "keywords": ""}, {"title": "Langerhans Cell Histiocytosis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Smoking Related Interstitial Pneumonias/Langerhans Cell Histiocytosis.html", "keywords": ""}, {"title": "Pathology of Granulomatous Interstitial Lung Disease", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Granulomatous Interstitial Lung Disease.html", "keywords": ""}, {"title": "Pathology of Sarcoidosis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Granulomatous Interstitial Lung Disease/Pathology of Sarcoidosis.html", "keywords": ""}, {"title": "Pathology of Nonfibrotic Hypersensitivity Pneumonitis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Granulomatous Interstitial Lung Disease/Pathology of Nonfibrotic Hypersensitivity Pneumonitis.html", "keywords": ""}, {"title": "Interstitial Lung Disease Associated with Systemic Inflammatory Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease.html", "keywords": "tissue bowel inflammatory associated medicine lung syndrome the 02 parenchyma interstitial systemic goodpasture disease-associated ild of disease granulomatosis pulmonary parenchymal polyangiitis igg4-related md with diffuse connective diseases"}, {"title": "Idiopathic Interstitial Pneumonias", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias.html", "keywords": "fibrosing medicine lung the eosinophilic pneumonias created 02 fibroelastosis interstitial parenchyma related acute pneumonia of others disease pulmonary chronic not parenchymal acute-subacute md idiopathic pleuropulmonary smoking diffuse diseases"}, {"title": "Chronic Fibrosing Interstitial Pneumonias", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Chronic Fibrosing Interstitial Pneumonias.html", "keywords": "fibrosis medicine lung the nonspecific pneumonias created 02 parenchyma interstitial pneumonia of ild disease pulmonary chronic not parenchymal md diseases idiopathic diffuse fibrotic non-ipf fibrosing"}, {"title": "Idiopathic Nonspecific Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Chronic Fibrosing Interstitial Pneumonias/Idiopathic Nonspecific Interstitial Pneumonia.html", "keywords": ""}, {"title": "Smoking Related Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Smoking Related Interstitial Pneumonia.html", "keywords": "medicine lung the bronchiolitis-associated pneumonias 02 parenchyma interstitial related pneumonia ild of disease pulmonary parenchymal respiratory md desquamative idiopathic smoking diffuse diseases"}, {"title": "Acute-Subacute Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Acute-Subacute Interstitial Pneumonia.html", "keywords": "cryptogenic medicine lung the pneumonias 02 interstitial parenchyma acute organizing pneumonia of disease pulmonary parenchymal acute-subacute md idiopathic diffuse diseases"}, {"title": "Acute Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Acute-Subacute Interstitial Pneumonia/Acute Interstitial Pneumonia.html", "keywords": ""}, {"title": "Cryptogenic Organizing Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Acute-Subacute Interstitial Pneumonia/Cryptogenic Organizing Pneumonia.html", "keywords": ""}, {"title": "Acute Eosinophilic Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Eosinophilic Lung Diseases/Acute Eosinophilic Pneumonia.html", "keywords": ""}, {"title": "Chronic Eosinophilic Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Eosinophilic Lung Diseases/Chronic Eosinophilic Pneumonia.html", "keywords": ""}, {"title": "Granulomatous Interstitial Lung Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease.html", "keywords": "pneumonitis medicine lung the 02 parenchyma interstitial sarcoidosis of ild disease lymphocytic pulmonary and parenchymal md other hypersensitivity diffuse granulomatous diseases"}, {"title": "Granulomatous Lymphocytic ILD and Other", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease/Granulomatous Lymphocytic ILD and Other.html", "keywords": ""}, {"title": "Diffuse Cystic Lung Diseases", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases.html", "keywords": "bronchiolitis lymphangioleiomyomatosis medicine hereditary lung syndrome the cystic 02 cell follicular parenchyma interstitial chain amyloidosis pneumonia of syndromes major langerhans disease pulmonary histiocytosis birt-hogg-dube minor deposition parenchymal dclds lymphoid md with light diffuse diseases"}, {"title": "Pulmonary Langerhans Cell Histiocytosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Pulmonary Langerhans Cell Histiocytosis.html", "keywords": ""}, {"title": "Lymphangioleiomyomatosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Lymphangioleiomyomatosis.html", "keywords": ""}, {"title": "Birt-Hogg-Dube Syndrome", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Birt-Hogg-Dube Syndrome.html", "keywords": ""}, {"title": "Lymphoid Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Lymphoid Interstitial Pneumonia.html", "keywords": ""}, {"title": "Amyloidosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Amyloidosis.html", "keywords": ""}, {"title": "Pulmonary Light Chain Deposition Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Pulmonary Light Chain Deposition Disease.html", "keywords": ""}, {"title": "Follicular Bronchiolitis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Follicular Bronchiolitis.html", "keywords": ""}, {"title": "Hereditary Syndromes with DCLDs", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Hereditary Syndromes with DCLDs.html", "keywords": ""}, {"title": "Iatrogenic Induced DPLD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Iatrogenic Induced DPLD.html", "keywords": "ild of induced md iatrogenic 02 parenchyma disease medicine pulmonary lung dpld drug-induced parenchymal the diffuse radiation diseases"}, {"title": "Radiation Induced ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Iatrogenic Induced DPLD/Radiation Induced ILD.html", "keywords": ""}, {"title": "Drug-Induced ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Iatrogenic Induced DPLD/Drug-Induced ILD.html", "keywords": ""}, {"title": "Inorganic Causes of DPLD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Inorganic Causes of DPLD.html", "keywords": "occupational md medicine pulmonary pneumoconioses and environmental 14 diseases"}, {"title": "Pneumoconioses", "url": "/Pulmonary Medicine/14. Occupational and Environmental Diseases/Pneumoconioses.html", "keywords": ""}, {"title": "Rare DPLD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD.html", "keywords": "congenital rare bronchiolitis medicine lung the constrictive adults lymphangiomatosis seen 02 parenchyma alveolar proteinosis of in disease pulmonary parenchymal microlithiasis erdheim-chester md dpld diffuse diseases"}, {"title": "Pulmonary Alveolar Proteinosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Pulmonary Alveolar Proteinosis.html", "keywords": ""}, {"title": "Pulmonary Alveolar Microlithiasis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Pulmonary Alveolar Microlithiasis.html", "keywords": ""}, {"title": "Erdheim-Chester Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Erdheim-Chester Disease.html", "keywords": ""}, {"title": "Diffuse Pulmonary Lymphangiomatosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Diffuse Pulmonary Lymphangiomatosis.html", "keywords": ""}, {"title": "Constrictive Bronchiolitis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Constrictive Bronchiolitis.html", "keywords": ""}, {"title": "Congenital Lung Disease Seen In Adults", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Congenital Lung Disease Seen In Adults.html", "keywords": ""}, {"title": "Eosinophilic Lung Diseases", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Eosinophilic Lung Diseases.html", "keywords": "pneumonitis malignancy primary vasculitides fungal associated medicine toxins lung disorders syndrome the myelodysplastic lymphoma - diffuse eosinophilic cystic induced created airways bronchocentric asthma allergic 02 parenchyma systemic secondary interstitial aspergillosis cell hypereosinophilic acute drug-induced bacterial pneumonia coccidioides of ild sarcoidosis langerhans disease granulomatosis pulmonary chronic leukemia not histiocytosis parenchymal airway polyangiitis aspergillus limited cancer drugs md with iatrogenic bronchitis bronchopulmonary idiopathic infections dpld hypersensitivity parasites granulomatous 01 diseases"}, {"title": "03. Sleep Medicine, Neuromuscular, and Skeletal", "url": "/Pulmonary Medicine/03. Sleep Medicine, Neuromuscular, and Skeletal.html", "keywords": ""}, {"title": "04. Epidemiology", "url": "/Pulmonary Medicine/04. Epidemiology.html", "keywords": ""}, {"title": "06. Neoplasia", "url": "/Pulmonary Medicine/06. Neoplasia.html", "keywords": ""}, {"title": "07. Pleural Disease", "url": "/Pulmonary Medicine/07. Pleural Disease.html", "keywords": ""}, {"title": "08. Quality, Safety, and Complications", "url": "/Pulmonary Medicine/08. Quality, Safety, and Complications.html", "keywords": ""}, {"title": "09. Transplantations", "url": "/Pulmonary Medicine/09. Transplantations.html", "keywords": ""}, {"title": "10. Vascular Diseases", "url": "/Pulmonary Medicine/10. Vascular Diseases.html", "keywords": ""}, {"title": "11. Respiratory Anatomy & Physiology", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology.html", "keywords": "measurements %26 fetal dioxide physiology 03 medicine for flow lung oxygenation 15 lungs relationships the breathing 11 transport carbon acid-base alveoli wall 07 status sleep-disordered clinical airways 02 12 anatomy ventilation strategies oxygen physiological function equilibrium diffusion of 10 cardiopulmonary basis protection pulmonary mechanics 09 ventilation-perfusion assessment gas and 05 respiratory md blood 13 08 04 control newborn 06 14 01 16 regulation chest"}, {"title": "11.01. The Airways & Alveoli", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli.html", "keywords": "points alveoli respiratory %26 physiology airways md 1 anatomy to remember pulmonary medicine 2 the 3 01 11"}, {"title": "11.01.2. The Alveoli", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.2. The Alveoli.html", "keywords": "cells secretion ii type membrane alveolar and macrophages mechanisms clearance capillary surfactant"}, {"title": "11.01.3. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.3. Points to Remember.html", "keywords": ""}, {"title": "11.02. The Lungs & Chest Wall", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall.html", "keywords": "%26 physiology nervous 5 remember medicine lung lungs the 3 11 as wall 02 anatomy supply thoracic of 1 pulmonary and points 2 4 musculature respiratory md blood to control organs 6 lymphatics chest"}, {"title": "11.02.1. The Lungs as Organs", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.1. The Lungs as Organs.html", "keywords": "pleural membranes"}, {"title": "11.02.2. Blood Supply to the Lungs", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.2. Blood Supply to the Lungs.html", "keywords": ""}, {"title": "11.02.3. Lymphatics of the Lung", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.3. Lymphatics of the Lung.html", "keywords": ""}, {"title": "11.02.4. Nervous Control of the Lungs and Thoracic Musculature", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.4. Nervous Control of the Lungs and Thoracic Musculature.html", "keywords": "innervation sensory somatic efferent motor autonomic responses afferent"}, {"title": "11.02.5. Thoracic Anatomy", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.5. Thoracic Anatomy.html", "keywords": "thoracic muscles sternomastoid cage diaphragm rib intercostal movements major abdominal pectoralis ventilatory muscle scalene"}, {"title": "11.02.6. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.6. Points to Remember.html", "keywords": ""}, {"title": "11.03. Mechanics of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation.html", "keywords": "%26 physiology remember on 03 medicine lung 3 11 wall anatomy compliance ventilation resistance of 1 pulmonary mechanics and points dynamic 2 airway 4 respiratory effects md to static chest"}, {"title": "11.03.1. Static Lung and Chest Wall Mechanics", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.1. Static Lung and Chest Wall Mechanics.html", "keywords": "capacities during law pressure-volume lung significance lungs relationships the maximum total wall cage hysteresis elastic compliance ventilation spirometry curves physiological expiratory interactions curve recoil of hooke's pressure rib diaphragm-abdomen distensibility thorax pulmonary inspiratory and tension nature disease mechanism surfactant relaxation components pressures change measurement gradients volume surface volumes composition -- static chest"}, {"title": "11.03.2. Dynamic Lung and Chest Wall Mechanics", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.2. Dynamic Lung and Chest Wall Mechanics.html", "keywords": "inflation law pressure-volume effect flow lung laminar plateau frictional isovolume the time or equation distribution effort-dependent airways compliance rate transitional constants ventilation regimens curves frequency resistance peak expiratory curve of nonelastic poiseuille's in tracheobronchial pressure turbulent mechanics and motion dependence gas effort-independent cephalad airway types dynamic to limitation pressure-flow bias exhalation"}, {"title": "11.03.3. Effects of Lung Compliance and Airway Resistance on Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.3. Effects of Lung Compliance and Airway Resistance on Ventilation.html", "keywords": "fatigue on effect work breathing muscular distribution weakness compliance ventilation trapping ventilatory pattern costs resistance of in pressure and gas auto-peep air effective inspired positive pleural gradients regional energy"}, {"title": "11.03.4. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.4. Points to Remember.html", "keywords": ""}, {"title": "11.04. Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation.html", "keywords": "%26 pattern%2c physiology remember medicine partial space 3 11 anatomy ventilation alveolar ventilatory pattern gases of 1 pulmonary and 05 points pressures 2 4 respiratory md to 04 dead space%2c classification"}, {"title": "11.04.1. Partial Pressures of Respiratory Gases", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.1. Partial Pressures of Respiratory Gases.html", "keywords": ""}, {"title": "11.04.2. Classification of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.2. Classification of Ventilation.html", "keywords": "dioxide anatomical minute space partial ratio or equation carbon total ventilation alveolar hypoventilation physiological of pressure and gas hyperventilation to measuring dead volume tidal composition"}, {"title": "11.04.3. Ventilatory Pattern, Dead Space, and Alveolar Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.3. Ventilatory Pattern, Dead Space, and Alveolar Ventilation.html", "keywords": ""}, {"title": "11.05.4. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.05.4. Points to Remember.html", "keywords": ""}, {"title": "11.05. Pulmonary Function Measurements", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.05. Pulmonary Function Measurements.html", "keywords": ""}, {"title": "11.06. Pulmonary Blood Flow", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.06. Pulmonary Blood Flow.html", "keywords": ""}, {"title": "11.07. Gas Diffusion", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.07. Gas Diffusion.html", "keywords": ""}, {"title": "11.08. Oxygen Equilibrium & Transport", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.08. Oxygen Equilibrium & Transport.html", "keywords": ""}, {"title": "11.09. Carbon Dioxide Equilibrium & Transport", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.09. Carbon Dioxide Equilibrium & Transport.html", "keywords": ""}, {"title": "11.10 Acid-Base Regulation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.10 Acid-Base Regulation.html", "keywords": ""}, {"title": "11.11. Control of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.11. Control of Ventilation.html", "keywords": ""}, {"title": "11.12. Ventilation-Perfusion Relationships", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.12. Ventilation-Perfusion Relationships.html", "keywords": ""}, {"title": "11.13. Clinical Assessment of Acid-Base & Oxygenation Status", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.13. Clinical Assessment of Acid-Base & Oxygenation Status.html", "keywords": ""}, {"title": "11.14. Physiological Basis for Oxygenation and Lung Protection Strategies", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.14. Physiological Basis for Oxygenation and Lung Protection Strategies.html", "keywords": ""}, {"title": "11.15. Physiology of Sleep-Disordered Breathing", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.15. Physiology of Sleep-Disordered Breathing.html", "keywords": ""}, {"title": "11.16. Fetal & Newborn Cardiopulmonary Physiology", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.16. Fetal & Newborn Cardiopulmonary Physiology.html", "keywords": ""}, {"title": "12. Pulmonary Symptoms", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms.html", "keywords": ""}, {"title": "13. Pulmonary Pathology", "url": "/Pulmonary Medicine/13. Pulmonary Pathology.html", "keywords": "of md 13 pneumonias interstitial disease pulmonary pathology lung medicine chronic idiopathic smoking acute related granulomatous injury fibrosing"}, {"title": "Critical Care Medicine", "url": "/Critical Care Medicine.html", "keywords": "endocrine%2c topics administration endocrine research%2c medicine disorders research renal%2c gastrointestinal - cardiovascular care ultrasound trauma trauma%2c | critical oncologic transplantation surgery neurologic scanning and metabolic surgery%2c md renal hematologic toxicology pharmacology ethics"}, {"title": "Cardiovascular Disorders", "url": "/Critical Care Medicine/Cardiovascular Disorders.html", "keywords": ""}, {"title": "Critical Care Ultrasound Scanning", "url": "/Critical Care Medicine/Critical Care Ultrasound Scanning.html", "keywords": ""}, {"title": "Gastrointestinal Disorders", "url": "/Critical Care Medicine/Gastrointestinal Disorders.html", "keywords": ""}, {"title": "Hematologic and Oncologic Disorders", "url": "/Critical Care Medicine/Hematologic and Oncologic Disorders.html", "keywords": ""}, {"title": "Neurologic Disorders", "url": "/Critical Care Medicine/Neurologic Disorders.html", "keywords": ""}, {"title": "Pharmacology and Toxicology", "url": "/Critical Care Medicine/Pharmacology and Toxicology.html", "keywords": ""}, {"title": "Renal, Endocrine, and Metabolic Disorders", "url": "/Critical Care Medicine/Renal, Endocrine, and Metabolic Disorders.html", "keywords": ""}, {"title": "Research, Administration and Ethics", "url": "/Critical Care Medicine/Research, Administration and Ethics.html", "keywords": ""}, {"title": "Surgery, Trauma, and Transplantation", "url": "/Critical Care Medicine/Surgery, Trauma, and Transplantation.html", "keywords": ""}, {"title": "Signs & Symptoms", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms.html", "keywords": "dyspnea %26 wheezing md 12 signs 1 medicine pulmonary symptoms 3 2 cough"}]